The 2nd Qatar Molecular Imaging Nuclear Medicine (MINM) conference is an opportunity for the professionals in this specialty:
- To update their knowledge on recent developments.
- To be aware of new MINM diagnostic and radiotracer therapy procedures and their applications in clinical practice.
- To refresh knowledge in quality control, quality assurance, and radiation safety.
- To develop contacts and establish collaboration in the clinical, academic, and research areas.
Overview:
We have invited 16 international and regional experts to present the updates and share their experiences. Nine clinical sessions are planned where 4 lectures will be delivered in each session. The first session will be dedicated to welcoming the delegates and for inauguration. Two sessions each are scheduled for PET/CT, General Nuclear Medicine, Cardiac PET and Nuclear Cardiology, and Theragnostic.
In addition to FDG PET/CT, conventional nuclear medicine, I-131 therapy, SPECT/CT, PEM, non-FDG PET/CT, PET/MRI, imaging in cardiac amyloidosis, AI, new therapy tracers, and conventional Nuclear Medicine in endocrine, renal, bone and GI disorders will also be covered by experts. There is a plan to organize a preconference Cardiac PET workshop on Nov 13. An attendee will have to choose to attend this workshop after registration without any additional fee.
There will be four parallel sessions on radiopharmaceutical, radiation safety, image processing, and reconstruction, and QC primarily for the scientists and technical staff working in nuclear medicine.
